Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis.

Heart Rhythm O2 · 2022 · PMC9626743 · PMID 36340491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Antithrombotic use and risk of hematoma Since both the use of AC and AP were highly significant in the multivariable model, risk of hematoma was evaluated in further detail based on the type of AC and the management strategy (interruption vs no interruption, heparin bridging vs no bridging) while also looking at AP therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.